Plasma Sphingolipid Profile Associated With Subclinical Atherosclerosis and Clinical Disease Markers of Systemic Lupus Erythematosus: Potential Predictive Value
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that affects females more than males, with African Americans developing more severe manifestation of the disease. SLE patients are at increased risk for cardiovascular disease (CVD), and SLE women 35-44 years old have 50 fold the inc...
Main Authors: | Samar M. Hammad, Olivia C. Harden, Dulaney A. Wilson, Waleed O. Twal, Paul J. Nietert, Jim C. Oates |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.694318/full |
Similar Items
-
Sphingolipids and Diagnosis, Prognosis, and Organ Damage in Systemic Lupus Erythematosus
by: Olivia C. Harden, et al.
Published: (2020-09-01) -
Thematic Review Series: Sphingolipids. Nuclear sphingolipids: metabolism and signaling*
by: Robert W. Ledeen, et al.
Published: (2008-06-01) -
Strong Alterations in the Sphingolipid Profile of Chickens Fed a Dose of Fumonisins Considered Safe
by: Didier Tardieu, et al.
Published: (2021-10-01) -
Antineoplastic Agents Targeting Sphingolipid Pathways
by: Alexander Kroll, et al.
Published: (2020-05-01) -
Sphingolipids: Important Players in Multiple Sclerosis
by: Ramona Halmer, et al.
Published: (2014-06-01)